A 44-year-old man with treated neurosyphilis presented with subclinical status epilepticus (SE) refractory to intravenous high-dose lorazepam, phenytoin, and valproic acid over 4 days. Ketamine infusion was instituted after low-dose propofol sedation with gradual control of electrographic seizures over 72h. Reevaluation 3 months later revealed diffuse cerebellar and worsened cerebral atrophy, consistent with animal models of N-methyl-D-aspartate antagonist-mediated neurotoxicity. Animal studies of prolonged ketamine therapy are required before widespread human use in SE.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s1525-5050(02)00643-1 | DOI Listing |
Publication Analysis
Top Keywords
status epilepticus
8
ketamine refractory
4
refractory status
4
epilepticus case
4
case ketamine-induced
4
ketamine-induced neurotoxicity
4
neurotoxicity 44-year-old
4
44-year-old man
4
man treated
4
treated neurosyphilis
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!